CASI
CASI Pharmaceuticals
CASIF pharma USA
Quick answer
CASI is a pharma company (CASIF) headquartered in BEIJING, F4, USA with 22 tracked pipeline programs.
Pipeline (22)
project
2-methoxyestradiol
Relapsed Multiple Myeloma
1 trials projectCID-103
Chronic Immune Thrombocytopenia
1 trials projectENMD-2076
Ovarian Cancer
1 trials projectENMD-2076
Advanced Adult Hepatocellular Carcinoma
1 trials projectENMD-2076
Triple Negative Breast Cancer
1 trials projectMKC-1
Breast Cancer
1 trials projectMKC-1
Advanced Cancer
2 trials projectMKC-1
Ovarian Cancer
1 trials projectMKC-1
Pancreatic Cancer
1 trials projectPanzem (2-methoxyestradiol) NCD, Avastin (Bevacizumab)
Carcinoid Tumor
1 trials projectPanzem NCD
Recurrent Glioblastoma Multiforme
1 trials projectPanzem Nanocrystal Colloidal Dispersion
Recurrent Glioblastoma Multiforme
1 trials projectPanzem Nanocrystal Colloidal Dispersion (NCD)
Ovarian Cancer
1 trials projectPanzem® NCD
Metastatic Renal Cell Carcinoma
1 trials projectPanzem® NCD
Prostate Cancer
1 trials projectrecombinant human Angiostatin protein
Carcinoma, Non-Small-Cell Lung
1 trials projectCID-103
Multiple Myeloma
1 trials projectENMD-2076
Advanced Cancer
1 trials projectENMD-2076
Multiple Myeloma
1 trials projectENMD-2076
Relapsed or Refractory Hematological Malignancies
1 trials projectMKC-1
Hematological Malignancies
1 trials projectmelphalan hydrochloride for injection
Multiple Myeloma
2 trials